Regen BioPharma, Inc. (RGBPP)

Market Cap	800.83K
Revenue (ttm)	236.56K
Net Income (ttm)	-867.25K
Shares Out	n/a
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	560
Average Volume	8,398
Open	0.0696
Previous Close	0.0566
Day's Range	0.0523 - 0.0696
52-Week Range	0.0300 - 0.8998
Beta	n/a
RSI	56.42
Earnings Date	n/a

About Regen BioPharma

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also developing HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase;...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RGBPP